Subjects: Biological Availability and United States / Titles: Bioavailability studies submitted in NDAs or INDs: general considerations - Digital Collections - National Library of Medicine Search Results

Start Over Subjects Biological Availability ✖ Subjects United States ✖ Titles Bioavailability studies submitted in NDAs or INDs: general considerations ✖

1. Bioavailability studies submitted in NDAs or INDs: general considerations

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, April 2022
Subject(s):: Biological Availability
Clinical Trials as Topic
Drug Approval
Drug Evaluation
Investigational New Drug Application
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration